A new study published by the International Journal of Molecular Sciences reports that several cannabinoids may have antibacterial activity against specific bacteria commonly linked to persistent endodontic infections.

Researchers from University of Detroit Mercy evaluated the antibacterial properties of cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC) against three pathogens frequently associated with failed root canal treatments: Enterococcus faecalis, Streptococcus mutans, and Fusobacterium nucleatum. These bacteria are known for their ability to survive conventional intracanal medicaments and contribute to ongoing infection.

To assess effectiveness, the team exposed planktonic forms of each bacterium to cannabinoids and compared the results with standard controls, including sodium hypochlorite. The study also measured minimum inhibitory concentrations and minimum bactericidal concentrations, while additional experiments evaluated cannabinoid effects on established bacterial biofilms using crystal violet assays and live/dead staining.

All three cannabinoids reached inhibitory concentrations against planktonic E. faecalis and S. mutans. A bactericidal concentration was identified for E. faecalis, though none of the cannabinoids fully eliminated S. mutans under the conditions tested. In biofilm experiments, increasing cannabinoid concentrations reduced bacterial viability in both E. faecalis and S. mutans. However, measurable biofilm degradation was observed only in E. faecalis.

In contrast, Fusobacterium nucleatum showed no inhibitory response to CBD, CBN, or THC at any tested concentration, highlighting a clear pathogen-specific response. According to the researchers, this selectivity suggests cannabinoids may interact differently with bacterial cell structures or metabolic pathways depending on the species.

The findings indicate that cannabinoids may have potential as adjunct antibacterial agents in dental care, particularly against pathogens known to persist in endodontic infections. The authors note that further research, including clinical studies, would be required to determine whether these laboratory results could translate into practical therapeutic applications.